The Inflammatory Bowel Disease (IBD) market refers to the products, external modalities, methods, strategies, service and treatments that targets IBD majorly including Crohn and Colitis and Ulcerative Colitis. IBD is a long-standing inflammatory disease of unknown cause that involves the gastrointestinal tract in a relapsing and remitting pattern. It extends to drugs and substances used in the treatment of severe diseases and includes therapeutic interventions such as drugs, biologics aimed at managing symptoms, achieving remission or enhancing patient’s quality of life once affected by such diseases. Given the increasing prevalence of IBD in population, caused by genetic factors, environmental conditions and lifestyle, the market has a great potential for development.

Influenza diagnostics refers to the methods and techniques used to detect and identify the presence of influenza viruses in clinical samples collected from patients suspected of having influenza infection. These diagnostics include various laboratory tests such as rapid antigen tests, molecular tests (like PCR), and viral cultures. The goal of influenza diagnostics is to accurately and quickly identify the influenza virus strain present to guide patient management, treatment decisions, and public health interventions, especially during flu seasons or outbreaks.

Ingestible Sensors Market Size Was Valued at USD 909.18 Million in 2023, and is Projected to Reach USD 2,320.06 Million by 2032, Growing at a CAGR of 10.97% From 2024-2032.

The rise in the Injectable drug delivery sector is primarily attributed to advancements in technology, a rise in chronic illnesses, and an increase in government support. The increasing number of elderly people worldwide is driving an increase in the need for healthcare services and medications. Elderly individuals often have complex healthcare needs and may need injectable medications for chronic conditions, leading to the growth of the injectable drug delivery sector.